Genetic epidemiology of Parkinson's disease

被引:33
作者
Payami, H
Zareparsi, S
机构
[1] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
关键词
D O I
10.1177/089198879801100207
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The cause of Parkinson's disease (PD) is unknown. The major risk factors identified to date are family history, age, and elements of rural living. Nearly one-third of all PD cases are familial, a small subset of which appears autosomal dominant; however, the majority exhibit no clear inheritance pattern. Autosomal dominant PD is genetically heterogeneous: two PD genes have been mapped to chromosomes 2 and 4 and there may be additional as yet unidentified genes. The common forms of PD-both familial and sporadic cases-appear to involve a complex interplay of genetic susceptibility and environmental exposure. The observations that rural residence and pesticide exposure increase the risk of developing PD, and that a synthetic drug, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, can cause parkinsonism, suggest that at least a subset of PD may be caused by a toxin. Furthermore, modest but significant associations have been reported between PD susceptibility and genes that regulate metabolism of drugs and neurotoxins. There is also evidence for mitochondrial dysfunction in PD, a finding that was recently traced to anomalies in mitochondrial DNA. At the present time, the genetics of PD appear to be complex, involving multiple nuclear genes and possibly mitochondrial genes as well.
引用
收藏
页码:98 / 106
页数:9
相关论文
共 135 条
[1]   ASSOCIATION BETWEEN THE OXIDATIVE POLYMORPHISM AND EARLY-ONSET OF PARKINSONS-DISEASE [J].
AGUNDEZ, JAG ;
JIMENEZJIMENEZ, FJ ;
LUENGO, A ;
BERNAL, ML ;
MOLINA, JA ;
AYUSO, L ;
VAZQUEZ, A ;
PARRA, J ;
DUARTE, J ;
CORIA, F ;
LADERO, JM ;
ALVAREZ, JC ;
BENITEZ, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (03) :291-298
[2]   FREQUENCY OF A SPECIFIC CYTOCHROME P4502D6B (CYP2D6B) MUTANT ALLELE IN CLINICALLY DIFFERENTIATED GROUPS OF PATIENTS WITH PARKINSON DISEASE [J].
AKHMEDOVA, SN ;
PUSHNOVA, EA ;
YAKIMOVSKY, AF ;
AVTONOMOV, VV ;
SCHWARTZ, EI .
BIOCHEMICAL AND MOLECULAR MEDICINE, 1995, 54 (02) :88-90
[3]   APOLIPOPROTEIN-E GENE IN PARKINSONS-DISEASE WITH OR WITHOUT DEMENTIA [J].
ARAI, H ;
MURAMATSU, T ;
HIGUCHI, S ;
SASAKI, H ;
TROJANOWSKI, JQ .
LANCET, 1994, 344 (8926) :889-889
[4]   MUTANT DEBRISOQUINE HYDROXYLATION GENES IN PARKINSONS-DISEASE [J].
ARMSTRONG, M ;
DALY, AK ;
CHOLERTON, S ;
BATEMAN, DN ;
IDLE, JR .
LANCET, 1992, 339 (8800) :1017-1018
[5]   Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease [J].
Bandmann, O ;
Vaughan, J ;
Holmans, P ;
Marsden, CD ;
Wood, NW .
LANCET, 1997, 350 (9085) :1136-1139
[6]   FAMILIAL SUBSETS IN IDIOPATHIC PARKINSONS-DISEASE [J].
BARBEAU, A ;
ROY, M .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) :144-150
[7]  
BARBEAU A, 1985, LANCET, V2, P1213
[8]   APOLIPOPROTEIN-E GENES IN LEWY BODY AND PARKINSONS-DISEASE [J].
BENJAMIN, R ;
LEAKE, A ;
EDWARDSON, JA ;
MCKEITH, IG ;
INCE, PG ;
PERRY, RH ;
MORRIS, CM .
LANCET, 1994, 343 (8912) :1565-1565
[9]   Absence of the G209A mutation in the α-synuclein gene in British families with Parkinson's disease [J].
Bennett, P ;
Nicholl, DJ .
NEUROLOGY, 1998, 50 (04) :1183-1183
[10]   FAMILIAL PARKINSONS-DISEASE - A CLINICAL GENETIC-ANALYSIS [J].
BONIFATI, V ;
FABRIZIO, E ;
VANACORE, N ;
DEMARI, M ;
MECO, G .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1995, 22 (04) :272-279